Ensol Biosciences Inc. (XKON:140610)
14,260
+780 (5.79%)
At close: Mar 5, 2026
-50.40% (1Y)
| Market Cap | 191.01B |
| Revenue (ttm) | 537.46M |
| Net Income (ttm) | -5.40B |
| Shares Out | 13.53M |
| EPS (ttm) | -644.00 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 20,108 |
| Average Volume | 14,906 |
| Open | 13,480 |
| Previous Close | 13,480 |
| Day's Range | 13,480 - 14,500 |
| 52-Week Range | 10,350 - 38,800 |
| Beta | 0.89 |
| RSI | 50.36 |
| Earnings Date | n/a |